ELOX 10-Q: SEC filing
Eloxx Pharmaceuticals
Filed with the SEC on · accession 0001193125-26-461189
ELOX filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -3.0% by the first close after the filing.
Summary of the filing
Eloxx Pharmaceuticals filed its Q3 2026 10-Q, reporting continued losses and a going concern situation with negative stockholders' equity, offset by various equity financings including pre-funded warrants and a securities purchase agreement.
Key details
How ELOX stock reacted
Close before
$13.15
Nov 13, 2026
First close after
-3.04%
$12.75
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ELOX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ELOX?
Click hereFrequently asked questions
What did ELOX file with the SEC on Nov 16, 2026?
ELOX filed a 10-Q (SEC filing). Eloxx Pharmaceuticals filed its Q3 2026 10-Q, reporting continued losses and a going concern situation with negative stockholders' equity, offset by various equity financings including pre-funded warrants and a securities purchase agreement.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
How did ELOX stock react to this filing?
ELOX closed at $13.15 before the filing and $12.75 on Nov 16, 2026 (-3.04%).
Other ELOX SEC filings
Get alerts when ELOX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days